Vistagen appoints Nick Tressler as CFO effective Dec 1, 2025

Vistagen Therapeutics, Inc.

Nick Tressler named CFO & Treasurer, effective Dec 1, 2025; succeeds Shawn Singh as interim PFO.
Starting annual base salary of $450,000; signing bonus of $50,000; target cash bonus of 45% of base.
Granted inducement option for 150,000 shares at $4.43 per share; vests over 4 years with 1-yr cliff.
Tressler brings 20+ years life sciences finance experience; most recently CFO at DYNEX Technologies.
Shawn Singh will no longer serve as interim principal financial and accounting officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.